Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> Scramble To Preorder COVID-19 Vaccines May Leave Poorer Countries Behind 14/08/2020 Grace Ren Health experts and access advocates warn that rich countries may leave poorer countries in the lurch as states scramble to preorder doses while COVID-19 vaccine candidates enter late stage clinical trials. The United Kingdom on Friday secured 90 million doses of two promising COVID-19 vaccine candidates, joining a growing group of rich countries buying up […] Continue reading -> Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others 12/08/2020 Grace Ren & Elaine Ruth Fletcher Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group. However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading -> Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
US Food And Drug Administration Commissioner Walks Back Claims On Plasma Treatment For Coronavirus 26/08/2020 Grace Ren The US Food and Drug Administration Commission Stephen Hahn on Monday apologized for overstating the effectiveness of convalescent plasma as a treatment for COVID-19, after the agency faced backlash for Hahn’s claims that the treatment could reduce mortality by as much as 35%, made during an announcement of the FDA emergency approval of the therapy […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> Scramble To Preorder COVID-19 Vaccines May Leave Poorer Countries Behind 14/08/2020 Grace Ren Health experts and access advocates warn that rich countries may leave poorer countries in the lurch as states scramble to preorder doses while COVID-19 vaccine candidates enter late stage clinical trials. The United Kingdom on Friday secured 90 million doses of two promising COVID-19 vaccine candidates, joining a growing group of rich countries buying up […] Continue reading -> Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others 12/08/2020 Grace Ren & Elaine Ruth Fletcher Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group. However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading -> Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> Scramble To Preorder COVID-19 Vaccines May Leave Poorer Countries Behind 14/08/2020 Grace Ren Health experts and access advocates warn that rich countries may leave poorer countries in the lurch as states scramble to preorder doses while COVID-19 vaccine candidates enter late stage clinical trials. The United Kingdom on Friday secured 90 million doses of two promising COVID-19 vaccine candidates, joining a growing group of rich countries buying up […] Continue reading -> Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others 12/08/2020 Grace Ren & Elaine Ruth Fletcher Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group. However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading -> Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States 17/08/2020 Grace Ren An breakthrough new COVID-19 saliva test, named SalivaDirect, received emergency use approval from the US Food and Drug Administration, potentially opening the door to broader testing. The new FDA-approved test, developed by researchers from the Yale School of Public Health, is about as sensitive as a traditional COVID-19 test, but is less invasive to perform, […] Continue reading -> Scramble To Preorder COVID-19 Vaccines May Leave Poorer Countries Behind 14/08/2020 Grace Ren Health experts and access advocates warn that rich countries may leave poorer countries in the lurch as states scramble to preorder doses while COVID-19 vaccine candidates enter late stage clinical trials. The United Kingdom on Friday secured 90 million doses of two promising COVID-19 vaccine candidates, joining a growing group of rich countries buying up […] Continue reading -> Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others 12/08/2020 Grace Ren & Elaine Ruth Fletcher Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group. However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading -> Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
Scramble To Preorder COVID-19 Vaccines May Leave Poorer Countries Behind 14/08/2020 Grace Ren Health experts and access advocates warn that rich countries may leave poorer countries in the lurch as states scramble to preorder doses while COVID-19 vaccine candidates enter late stage clinical trials. The United Kingdom on Friday secured 90 million doses of two promising COVID-19 vaccine candidates, joining a growing group of rich countries buying up […] Continue reading -> Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others 12/08/2020 Grace Ren & Elaine Ruth Fletcher Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group. However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading -> Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others 12/08/2020 Grace Ren & Elaine Ruth Fletcher Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group. However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading -> Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really? 10/08/2020 Elaine Ruth Fletcher More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
“A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
No Corners Being Cut On Safety, In the Quest For A COVID-19 Vaccine, Says WHO 06/08/2020 Grace Ren In the unprecedented race to develop a COVID-19 vaccine, the World Health Organization says that there are no “cutting corners” in testing the safety and efficacy of a new vaccine candidate. Vaccine development has moved at an unprecedented pace. In six months, some 26 candidates are already undergoing human testing, while 139 more are in […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts
EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> Posts navigation Older postsNewer posts